EX-10.3 4 aethlon_ex1003.htm BUDGET FOR UCI CLINICAL TRIAL

Exhibit 10.3

 

Protocol No.: UCI 14-25 Plasma Exosome Concentration in Cancer Patients Undergoing Treatment

 

Protocol Target Accrual: 45                                                                              PI: Edward Nelson, MD

Short Title: Plasma Exosome Concentration in Cancer Patients Undergoing Treatment

 

Startup Charges

Event Negotiated Charge
   
Protocol Set-Up & Administration Fees (Feasibility, Budget, Medicare Cost Coverage, IRB Application/Doc Prep, IRB Institutional Review Fee, Annual CRC Administrative Fees, and Study Supplies)

15,105.00    

 

Subtotal:   15,105.00 
Overhead Charges @ 0.0%:   0.00 
Indirect Costs @ 26.0%:   3,927.30 
Total Startup Charges:   19,032.30 

 

Per Subject Visit Charges (Items include 26.0% indirect charges)

 

# occurances Event # of Subjects Visit Reimbursement
1 Phlebotomy 45 84.00
1 Cancer Center Data Management 45 1,497.00
1 Study Oversight, Coordination, and Biostatistics 45 1,778.00
  Total Subject Charges (Maximum)   3,359.00

 

Direct Cost Subtotal for (1) Subjects:   2,665.87 
Indirect Costs @ 26.0%:   693.13 
Total Per Subject Charges for (1) Subjects   3,359.00 
Total Per Subject Charges for (45) Subjects   151,155.00 

 

Protocol Related Variable Passthrough Charges (Items include 26.0% indirect charges)

 

Event   Negotiated Charge 
Protocol Annual Renewal Prep Fee (Payment triggered at IRB renewal. Includes study project management outside visit activities for sponsor site visits, IRB renewal prep, bill reconciliation, OnCore managment, SAE reporting, IRB modifications, close out and storage, etc.)   7,000.00 
IRB Committee Renewal Review Fee   1,039.50 
Consent Translation (Pass through cost, based on language and length of document)   TBD 
Other Tests/Procedures not included above   TBD